Press Releases Year None2021202020192018201720162015201420132012 January 20, 2021 Aclaris Announces Pricing of Public Offering of Common Stock January 19, 2021 Aclaris Announces Proposed Public Offering of Common Stock January 19, 2021 Aclaris Therapeutics Announces Positive Preliminary Topline Data from 12-Week Phase 2a Trial of Oral ATI-450 for Moderate to Severe Rheumatoid Arthritis Load More »